ATE322908T1 - Ein kombinationsprodukt enthaltend melagatran und einen faktor xa inhibitor - Google Patents

Ein kombinationsprodukt enthaltend melagatran und einen faktor xa inhibitor

Info

Publication number: ATE322908T1
Authority: AT; Austria
Prior art keywords: combination product; inhibitor; factor; product containing; melagatran
Prior art date: 2000-06-10

Application number

AT01938923T

Other languages

English (en)

Inventor

Christer Mattsson

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-10

Filing date

2001-06-06

Publication date

2006-04-15

2001-06-06 Application filed filed Critical

2006-04-15 Application granted granted Critical

2006-04-15 Publication of ATE322908T1 publication Critical patent/ATE322908T1/de

Links

239000013066 combination product Substances 0.000 title abstract 3
229940127555 combination product Drugs 0.000 title abstract 3
229940123583 Factor Xa inhibitor Drugs 0.000 title abstract 2
DKWNMCUOEDMMIN-PKOBYXMFSA-N melagatran Chemical compound C1=CC(C(=N)N)=CC=C1CNC(=O)[C@H]1N(C(=O)[C@H](NCC(O)=O)C2CCCCC2)CC1 DKWNMCUOEDMMIN-PKOBYXMFSA-N 0.000 title abstract 2
229960002137 melagatran Drugs 0.000 title abstract 2
239000002671 adjuvant Substances 0.000 abstract 1
239000003146 anticoagulant agent Substances 0.000 abstract 1
229940127219 anticoagulant drug Drugs 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Liquid Crystal Substances (AREA)
Hydrogenated Pyridines (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Iron Core Of Rotating Electric Machines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT01938923T 2000-06-10 2001-06-06 Ein kombinationsprodukt enthaltend melagatran und einen faktor xa inhibitor ATE322908T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0014136.6A GB0014136D0 (en)	2000-06-10	2000-06-10	Combination therapy

Publications (1)

Publication Number	Publication Date
ATE322908T1 true ATE322908T1 (de)	2006-04-15

Family

ID=9893354

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01938923T ATE322908T1 (de)	2000-06-10	2001-06-06	Ein kombinationsprodukt enthaltend melagatran und einen faktor xa inhibitor

Country Status (22)

Country	Link
US (1)	US20030158120A1 (de)
EP (1)	EP1294394B1 (de)
JP (1)	JP2004503508A (de)
KR (1)	KR20030007939A (de)
CN (1)	CN1431912A (de)
AT (1)	ATE322908T1 (de)
AU (2)	AU2001264494B2 (de)
BR (1)	BR0111545A (de)
CA (1)	CA2410100A1 (de)
CY (1)	CY1105068T1 (de)
DE (1)	DE60118732T2 (de)
DK (1)	DK1294394T3 (de)
ES (1)	ES2260225T3 (de)
GB (1)	GB0014136D0 (de)
HK (1)	HK1052463B (de)
IL (1)	IL152897A0 (de)
MX (1)	MXPA02011780A (de)
NO (1)	NO20025909L (de)
NZ (1)	NZ522866A (de)
PT (1)	PT1294394E (de)
WO (1)	WO2001095931A1 (de)
ZA (1)	ZA200209487B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0103590D0 (sv)	2001-10-26	2001-10-26	Astrazeneca Ab	New Combination
GB0306615D0 (en) *	2003-03-22	2003-04-30	Astrazeneca Ab	New use
WO2007008145A1 (en) *	2005-07-08	2007-01-18	Astrazeneca Ab	Heterocyclic sulfonamide derivatives as inhibitors of factor xa
AR062057A1 (es) *	2006-07-17	2008-10-15	Boehringer Ingelheim Int	Uso de los inhibidores directos de la trombina
US8790924B2 (en)	2006-10-19	2014-07-29	Duke University	Reversible platelet inhibition
EP2667878B1 (de)	2011-01-25	2016-03-30	Université Catholique de Louvain	Zusammensetzungen und verfahren zur zelltransplantation
US9687529B2 (en)	2011-05-05	2017-06-27	Duke University	Method of controlling coagulation
US9775890B2 (en)	2012-01-25	2017-10-03	Université Catholique de Louvain	Factor Xa inhibitor used with liver-derived progenitor cells
EP3016665B1 (de)	2013-07-05	2019-09-18	Université Catholique de Louvain	Konditioniertes medium aus menschlichen adulten leberstammzellen und verwendung davon bei der behandlung von lebererkrankungen
EP2843416A1 (de) *	2013-09-02	2015-03-04	Siemens Healthcare Diagnostics Products GmbH	Kontroll- und Kalibratormaterial für die Bestimmung von direkten Antikoagulanzien
WO2016176426A1 (en)	2015-04-28	2016-11-03	Duke University	Thrombus imaging aptamers and methods of using same
EP3512526A4 (de)	2016-09-16	2020-05-27	Duke University	Gegen von-willebrand-faktor (vwf) gerichtete wirkstoffe und verfahren zur verwendung davon
US11654036B2 (en)	2020-05-26	2023-05-23	Elixir Medical Corporation	Anticoagulant compounds and methods and devices for their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9601556D0 (sv) *	1996-04-24	1996-04-24	Astra Ab	New pharmaceutical formulation of a thrombin inhibitor for parenteral use

2000
- 2000-06-10 GB GBGB0014136.6A patent/GB0014136D0/en not_active Ceased
2001
- 2001-06-06 US US10/297,537 patent/US20030158120A1/en not_active Abandoned
- 2001-06-06 ES ES01938923T patent/ES2260225T3/es not_active Expired - Lifetime
- 2001-06-06 PT PT01938923T patent/PT1294394E/pt unknown
- 2001-06-06 IL IL15289701A patent/IL152897A0/xx unknown
- 2001-06-06 MX MXPA02011780A patent/MXPA02011780A/es active IP Right Grant
- 2001-06-06 AU AU2001264494A patent/AU2001264494B2/en not_active Ceased
- 2001-06-06 BR BR0111545-6A patent/BR0111545A/pt not_active IP Right Cessation
- 2001-06-06 KR KR1020027016819A patent/KR20030007939A/ko not_active Ceased
- 2001-06-06 NZ NZ522866A patent/NZ522866A/en unknown
- 2001-06-06 HK HK03104744.8A patent/HK1052463B/en not_active IP Right Cessation
- 2001-06-06 EP EP01938923A patent/EP1294394B1/de not_active Expired - Lifetime
- 2001-06-06 CN CN01810227A patent/CN1431912A/zh active Pending
- 2001-06-06 JP JP2002510108A patent/JP2004503508A/ja active Pending
- 2001-06-06 AU AU6449401A patent/AU6449401A/xx active Pending
- 2001-06-06 WO PCT/SE2001/001288 patent/WO2001095931A1/en not_active Ceased
- 2001-06-06 AT AT01938923T patent/ATE322908T1/de not_active IP Right Cessation
- 2001-06-06 DK DK01938923T patent/DK1294394T3/da active
- 2001-06-06 DE DE60118732T patent/DE60118732T2/de not_active Expired - Fee Related
- 2001-06-06 CA CA002410100A patent/CA2410100A1/en not_active Abandoned
2002
- 2002-11-21 ZA ZA200209487A patent/ZA200209487B/en unknown
- 2002-12-09 NO NO20025909A patent/NO20025909L/no not_active Application Discontinuation
2006
- 2006-07-07 CY CY20061100937T patent/CY1105068T1/el unknown

Also Published As

Publication number	Publication date
DK1294394T3 (da)	2006-07-10
ZA200209487B (en)	2004-02-23
JP2004503508A (ja)	2004-02-05
WO2001095931A1 (en)	2001-12-20
US20030158120A1 (en)	2003-08-21
AU2001264494B2 (en)	2006-01-05
PT1294394E (pt)	2006-07-31
ES2260225T3 (es)	2006-11-01
EP1294394A1 (de)	2003-03-26
NO20025909L (no)	2003-02-07
NO20025909D0 (no)	2002-12-09
IL152897A0 (en)	2003-06-24
CA2410100A1 (en)	2001-12-20
CN1431912A (zh)	2003-07-23
AU6449401A (en)	2001-12-24
HK1052463B (en)	2006-10-13
CY1105068T1 (el)	2010-03-03
DE60118732D1 (de)	2006-05-24
DE60118732T2 (de)	2006-10-05
NZ522866A (en)	2004-09-24
GB0014136D0 (en)	2000-08-02
EP1294394B1 (de)	2006-04-12
HK1052463A1 (en)	2003-09-19
MXPA02011780A (es)	2003-04-10
KR20030007939A (ko)	2003-01-23
BR0111545A (pt)	2003-07-01

Legal Events

Date

Code

Title

Description

2007-01-15

UEP

Publication of translation of european patent specification

Ref document number: 1294394

Country of ref document: EP

2009-03-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
GEP20063805B (en)	2006-04-25	Alkyne-Arylnaphthyridin-4-one as Phosphodiesterase-4 Inhibitors
MXPA03007140A (es)	2004-05-24	Derivados de carbolina.
GEP20053692B (en)	2005-12-12	Substituted Alkylamine Derivatives and Methods of Use
ATE322908T1 (de)	2006-04-15	Ein kombinationsprodukt enthaltend melagatran und einen faktor xa inhibitor
MXPA02012076A (es)	2003-06-06	Compuestos quimicos.
AU2001266575A1 (en)	2002-01-08	Chemical compounds
DE60216233D1 (en)	2007-01-04	Carbolinderivate
MXPA03002911A (es)	2003-09-10	Compuestos quimicos.
ATE303384T1 (de)	2005-09-15	1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
GB0018951D0 (en)	2000-09-20	Novel compounds
MXPA02012472A (es)	2004-01-26	Compuestos quimicos.
DK1294395T3 (da)	2006-07-24	Kombinationsprodukt indeholdende melagatran og en faktor VIIa inhibitor
MXPA06000372A (es)	2006-03-30	Compuestos de silicio y su uso.
GB0027705D0 (en)	2000-12-27	Novel compounds
MXPA04001121A (es)	2004-05-20	Derivados de fenilo.
SE0103590D0 (sv)	2001-10-26	New Combination
ATE342907T1 (de)	2006-11-15	Tumorhemmende lanthanverbindungen
MX2008001548A (es)	2008-04-04	Compuestos antitumorales.
DE60220504D1 (en)	2007-07-19	Tryptasehemmer
SI1358182T1 (en)	2005-02-28	Diazocine derivates and their use as tryptase inhibitors
DOP2002000405A (es)	2002-11-30	1-biaril-1,8-naftiridin-4-ona inhibidores de la fosfodisterasa-4.
MXPA03011724A (es)	2004-03-19	Derivados de carbohidratos.